Custom service
Cyclic Peptide Conjugation
Conjugate cyclic peptides to carriers, labels or payloads without breaking the ring
Cyclic Peptide Conjugation supports programmes that conjugate cyclic peptides to carriers, labels or payloads without breaking the ring. In a typical engagement we plan the handle-first ring design route first, confirm compatibility with orthogonal conjugation on cyclic scaffolds, and release cyclic conjugate with loading and connectivity QC on a 4–6 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep handle-first ring design as the primary option and hold orthogonal conjugation on cyclic scaffolds in reserve, so that scale-up never depends on an unproven step.
Cyclic targeting motifs on drug conjugates
Biotinylated or fluorescent cyclic probes
Conjugation chemistries that reduce disulfide cycles
Cycles whose ring size is known to be geometrically uncloseable
Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.
Service Highlights
- Handle-first ring design as the default route, with orthogonal conjugation on cyclic scaffolds held as a proven fallback
- Post-cyclization labeling worked into the design where the application requires it
- Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
- Analytical confirmation of every intermediate before the final release
- Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
- Cyclic conjugate with loading and connectivity QC delivered with a complete conjugation or synthesis certificate
How the work runs
Precursor design
Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Conjugation ring size.
Linear assembly
The precursor chain is assembled with Fmoc chemistry and handle-first ring design where relevant.
Cyclization
Ring closure is executed by orthogonal conjugation on cyclic scaffolds under screened dilution and activation conditions.
Isomer separation
RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.
Characterization
Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.
Release
Cyclic conjugate with loading and connectivity QC is documented and released after QC sign-off.
Specifications & timeline
- Turnaround
- 4–6 weeks
- Typical scale
- 1 – 200 mg cyclic peptide
- Chemistry options
- handle-first ring design; orthogonal conjugation on cyclic scaffolds; post-cyclization labeling
- Deliverable
- Cyclic conjugate with loading and connectivity QC
- QC package
- HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
- Shipping
- Ambient with desiccant; blue ice for sensitive motifs
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.